The Anti-Atherogenic Potential of Liposome-Mediated Delivery of LXR Agonists to Macrophages: A Preclinical Validation Study

Atherosclerosis Supplements - Ireland
doi 10.1016/j.atherosclerosissup.2018.04.021

Related search